Financhill
Sell
50

TKPHF Quote, Financials, Valuation and Earnings

Last price:
$29.61
Seasonality move :
6.66%
Day range:
$29.61 - $29.61
52-week range:
$24.25 - $32.13
Dividend yield:
4.47%
P/E ratio:
187.88x
P/S ratio:
1.59x
P/B ratio:
0.97x
Volume:
6
Avg. volume:
78.1K
1-year change:
21.1%
Market cap:
$46.8B
Revenue:
$30.1B
EPS (TTM):
$0.16

Earnings Data

Next earnings date for TKPHF
Jan 29
2026
Most recent earnings per share
-$0.05
Missed by $0.05
(Oct 30/2025)
Consensus Estimate
--
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TKPHF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/29/2026 Q4 $7.8B -- -- -- --
10/30/2025 Q3 $7.8B $7.5B -$0.05 -- --
07/30/2025 Q2 $7.9B $7.7B $0.54 -- --
05/08/2025 Q1 $7.6B $6.9B -$0.43 -- --
01/30/2025 Q4 $7.3B $7.5B $0.10 -- --
10/31/2024 Q3 $7.2B $7.9B $0.39 -- --
07/31/2024 Q2 $6.8B $7.7B $0.38 -- --
05/09/2024 Q1 $5.8B $7.1B -$0.01 -- --
02/01/2024 Q4 $6.8B $7.5B $0.45 -- --
09/30/2023 Q3 -- -- -$0.21 -- --
07/27/2023 Q2 -- -- $0.42 -- --
05/11/2023 Q1 -- -- $0.15 -- --
02/02/2023 Q4 -- -- $0.54 -- --
10/27/2022 Q3 -- -- $0.29 -- --
07/28/2022 Q2 -- -- $0.52 -- --
05/11/2022 Q1 -- -- -$0.06 -- --
02/03/2022 Q4 -- -- $0.32 -- --
10/28/2021 Q3 -- -- $0.26 -- --
07/30/2021 Q2 -- -- $0.80 -- --
05/11/2021 Q1 -- -- $1.18 -- --
02/04/2021 Q4 -- -- $0.56 -- --
10/29/2020 Q3 -- -- $0.02 -- --
07/31/2020 Q2 -- -- $0.49 -- --
05/13/2020 Q1 -- -- $0.01 -- --
02/04/2020 Q4 -- -- -$0.19 -- --
10/31/2019 Q3 -- -- $0.40 -- --
07/31/2019 Q2 -- -- $0.04 -- --
05/14/2019 Q1 -- -- -$0.17 -- --
02/01/2019 Q4 -- -- $0.42 -- --
10/31/2018 Q3 -- -- $0.55 -- --
07/31/2018 Q2 -- -- $0.91 -- --
05/14/2018 Q1 -- -- -$0.64 -- --
02/01/2018 Q4 -- -- $0.77 -- --
11/01/2017 Q3 -- -- $0.32 -- --
07/28/2017 Q2 -- -- $1.66 -- --
05/10/2017 Q1 -- -- -$0.57 -- --
02/01/2017 Q4 -- -- $0.48 -- --
10/28/2016 Q3 -- -- $0.31 -- --
07/29/2016 Q2 -- -- $1.17 -- --
03/31/2016 Q1 -- -- -$0.37 -- --
12/31/2015 Q4 -- -- $0.62 -- --

Takeda Pharmaceutical Co., Ltd. Earnings Questions

  • How Much did Takeda Pharmaceutical Co., Ltd. Generate in Revenue Last Quarter?

    Takeda Pharmaceutical Co., Ltd. reported $7.5B worth of top line sales in its most recent quarter.

  • Did Takeda Pharmaceutical Co., Ltd. Beat Earnings Last Quarter?

    Takeda Pharmaceutical Co., Ltd. announced earnings per share of -$0.05 which represents a miss of analyst forecast a -- per share.

  • Is Takeda Pharmaceutical Co., Ltd. Profitable?

    Takeda Pharmaceutical Co., Ltd. reported $3.6B that represents $2.26 per share over the last quarter.

  • What is the Analyst Consensus for Takeda Pharmaceutical Co., Ltd. EPS Next Year?

    Takeda Pharmaceutical Co., Ltd.'s earnings are forecast to grow from $0.44 per share to -- per share next year representing an increase of --.

  • When is Takeda Pharmaceutical Co., Ltd.'s Earnings Date?

    Takeda Pharmaceutical Co., Ltd.'s next earnings date is January 29, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock